Toft M, Myhre R, Pielsticker L, White L R, Aasly J O, Farrer M J
Department of Neuroscience, Norwegian University of Science and Technology (NTNU), N-7489 Trondheim, Norway.
J Neurol Neurosurg Psychiatry. 2007 Jan;78(1):82-4. doi: 10.1136/jnnp.2006.097840.
Mutations in the PTEN-induced kinase 1 (PINK1) gene have been identified in recessively inherited and sporadic early-onset parkinsonism (EOP).
A total of 131 Norwegian patients diagnosed with Parkinson's disease were included. Of them, 89 participants had EOP (onset < or = 50 years); the remaining had familial late-onset disease (mean age at onset 64 years). PINK1 analysis included sequencing and gene dose assessment. Mutations were examined in 350 controls.
Heterozygous missense mutations in PINK1 were found in 3 of 131 patients; none of the patients carried homozygous or compound heterozygous mutations. One of these three patients had a father affected by Parkinson's disease, and he carried the mutation. Three new and seven known polymorphic variants were identified, although none seemed to be associated with disease risk.
PINK1 mutations are rare in Norwegian patients with EOP and familial Parkinson's disease. However, the data suggest that some heterozygous mutations might increase the risk of developing Parkinson's disease.
在隐性遗传和散发性早发性帕金森病(EOP)中已发现磷酸酶及张力蛋白同源物诱导激酶1(PINK1)基因突变。
纳入131例诊断为帕金森病的挪威患者。其中,89例参与者患有早发性帕金森病(发病年龄≤50岁);其余患者患有家族性晚发性疾病(平均发病年龄64岁)。PINK1分析包括测序和基因剂量评估。在350名对照中检测突变情况。
131例患者中有3例发现PINK1杂合错义突变;无患者携带纯合或复合杂合突变。这3例患者中有1例患者的父亲患有帕金森病,且他携带该突变。鉴定出3个新的和7个已知的多态性变体,尽管似乎没有一个与疾病风险相关。
PINK1突变在挪威早发性帕金森病患者和家族性帕金森病患者中罕见。然而,数据表明一些杂合突变可能会增加患帕金森病的风险。